Lars-Petter Jelsness-Jørgensen

11PUBLICATIONS
36CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Cardiology (incl. cardiovascular diseases)Predictive and prognostic markersNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 06, 2026
Anti-TNF withdrawal or long-term treatment in ulcerative colitis (BIOSTOP): a multicentre open label, randomized controlled trial.

|Mar 10, 2025
Prevalence of Irritable Bowel Syndrome Based on Rome IV Criteria in Patients in Biochemical and Endoscopic Remission From Newly Diagnosed Inflammatory Bowel Disease: One- and Three-Year Results (the IBSEN III Cohort).

Bjorn Christian Olsen, Randi Opheim, Vendel A Kristensen

|Jan 09, 2024
Coeliac disease in the Trøndelag Health Study (HUNT), Norway, a population-based cohort of coeliac disease patients.

Polina Lukina, Ina Lervåg Andersen, Petter Tinbod Eggen

|Jun 20, 2023
Incidence of cancer in patients with ulcerative colitis 30 years after diagnosis (the IBSEN study).

Benoit Follin-Arbelet, Milada Cvancarova Småstuen, Øistein Hovde

|Feb 21, 2022
Antitumour necrosis factor alpha treatment in Crohn's disease: long-term efficacy, side effects and need for surgery.

Frode Lerang, René Holst, Magne Henriksen

|Jan 25, 2022
The multidimensional fatigue inventory (MFI-20): psychometrical testing in a Norwegian sample of inflammatory bowel disease (IBD) patients.

Lars-Petter Jelsness-Jørgensen, Bjørn Moum, Tore Grimstad

Pageof 2

Frequent Collaborators

4 joint publications

Randi Opheim

3 joint publications

Jørgen Jahnsen

3 joint publications

Gert Huppertz-Hauss

2 joint publications

Vendel Kristensen